v3.26.3
Condensed Balance Sheets (Parenthetical) - USD ($)
 3 Months Ended 6 Months Ended
Jul. 31, 2026
Jan. 31, 2026
Jul. 31, 2026
Jul. 31, 2026
Ordinary shares, par value $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 500,000,000 500,000,000 500,000,000 500,000,000
Ordinary shares, shares issued 10,500,000 10,500,000 10,500,000 10,500,000
Ordinary shares, redemption par value $ 10.13 $ 10.13 $ 10.13 $ 10.13
Temporary equity, subject to possible redemption 0 0 0 0
Ordinary shares, par value $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 500,000,000 500,000,000 500,000,000 500,000,000
Ordinary shares, shares issued [2] 3,001,250 [1] 2,875,000 3,001,250 [1] 3,001,250 [1]
Ordinary shares, shares outstanding [2] 3,001,250 [1] 2,875,000 3,001,250 [1] 3,001,250 [1]
Shares issued       2,875,000
Purchase price     $ 234,000  
Over-Allotment Option [Member]        
Number of ordinary shares forfeited during the period 250,000 375,000    
[1] As a result of the partial exercise of the underwriters’ over-allotment option to purchase 500,000 Units, which closed on May 27, 2026, 125,000 of the 375,000 Founder Shares were no longer subject to forfeiture. The remaining 250,000 Founder Shares were forfeited for no consideration upon expiration of the unexercised portion of the over-allotment option in June 2026.
[2] Ordinary shares have been retroactively restated to reflect the issuance of an additional 1,150,000 Founder Shares to the Sponsor for no consideration on February 20, 2026, resulting in an aggregate of 2,875,000 Founder Shares held by the Sponsor (of which 1,725,000 Founder Shares were originally issued on September 29, 2025 for an aggregate purchase price of $25,000), including an aggregate of up to 375,000 Founder Shares that were subject to forfeiture to the extent the underwriters’ Over-Allotment Option was not exercised in full or in part (see Note 5).